Tag Archive: FDA

by Jody Ranck | April 12, 2021

Digital Twins 101

Digital twins provide more dynamic models than conventional simulations and will provide valuable tools for precision medicine. Learn more in this deep dive article.

by Chilmark Team | December 18, 2020

Looking to the Future – 2021 Predictions

Unlike past years when we have written a post evaluating how well our predictions for that year held up, let’s […]

by Jody Ranck | October 15, 2020

AI and Recent Regulatory, Policy and Funding Updates

While COVID-19 has been dominating the healthcare headlines so far in 2020 there have been a number of recent policy and regulatory decisions bearing on the AI/ML market in healthcare.

by Alex Lennox-Miller | January 30, 2020

Guidance on Clinical Decision Support: Definitions and Transparency

Roughly two years after we reviewed the first FDA guidance on Clinical Decision Support (CDS), FDA issued new draft guidance. […]

by Chilmark Team | December 10, 2018

2019 Predictions: M&A, Big Tech, and the Fate of ACOs

The Meaningful Use gravy train finally came to an end in 2018. As the strongest EHR vendors struggle to define […]

by Chilmark Team | November 29, 2018

Revisiting Our 2018 Predictions

As is our custom here, we like to look back on our predictions for the closing year and see just […]

by Brian Edwards | December 19, 2017

FDA Guidance on Clinical Decision Support: Peering Inside the Black Box of Algorithmic Intelligence

Key Takeaways: The FDA has released long-anticipated draft guidance on how they intend to regulate clinical decision support products. For […]

by Naveen Rao | July 27, 2015

Connected Care: Are We There Yet?

Progress? Healthcare organizations (HCOs) are acknowledging the need for next generation tools to realize the promise of newer models of […]

Stay up to the minute.

[bestwebsoft_contact_form]